期刊文献+

容桂地区育龄妇女多囊卵巢综合征患病率及临床特征调查 被引量:4

Investigation on prevalence and clinical characteristics of women at childbearing age with polycystic ovary syndrome in Ronggui area
原文传递
导出
摘要 目的:调查容桂地区育龄妇女多囊卵巢综合征(PCOS)的患病率,探讨该地区PCOS的临床特点。方法:采取整群随机抽样的方法抽取1 000例育龄妇女作为调查对象。按照ESHRE/ASRM诊断标准,进行问卷调查、体格检查及超声检查。对于可疑PCOS者,于第二天空腹抽血检测性激素6项、空腹血清胰岛素、空腹血糖。患者确诊后,抽取相同例数正常对照人群同时进行相同指标检测,比较正常对照组和PCOS组的生化指标。结果:在接受调查的1 000例本地区育龄妇女中确诊PCOS病例63例,占全部调查人群的6.3%。PCOS患者的临床表现包括不孕、卵巢多囊性改变、月经异常、痤疮、多毛、肥胖等,伴有性激素及血清胰岛素水平的改变。结论:本地区育龄妇女PCOS患病率为6.3%,临床表现以卵巢多囊性改变、月经异常、肥胖为主。 Objective:To investigate the prevalence of polycystic ovary syndrome(PCOS) in women at childbearing age in Ronggui area,explore the clinical characteristics of PCOS in the area.Methods:Cluster random sampling method was used to select 1 000 women at childbearing age as respondents;questionnaire survey,physical examination,and ultrasonography were performed according to ESHRE/ASRM diagnostic criteria.For the women suspected of PCOS,six items of sex hormones,fasting serum insulin,and fasting blood glucose were detected on the second day by Abstracting fasting blood samples.A total of 1 000 normal women were selected as control group after definite diagnosis,and the same indexes were detected,the biological indexes were compared between control group and PCOS group.Results:Among 1 000 women of childbearing age in the area,63 women were diagnosed as PCOS definitely,accounting for 6.3% of all the respondents.The clinical manifestations of patients with PCOS included infertility,polycystic ovary,menstrual disorder,acne,hypertrichosis,and obesity,accompanied with changes of sex hormones and serum insulin levels.Conclusion:The prevalence of PCOS in the women of childbearing age in Ronggui area was 6.3%,the main clinical manifestations included polycystic ovary,menstrual disorder,and obesity.
出处 《中国妇幼保健》 CAS 北大核心 2012年第24期3776-3778,共3页 Maternal and Child Health Care of China
基金 广东省佛山市医学类科技攻关项目〔201008203〕
关键词 多囊卵巢综合征 患病率 临床特征 Polycystic ovary syndrome Prevalence Clinical characteristics
  • 相关文献

参考文献13

  • 1Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Work-shop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(J).Fertil Steril,2004,81(1):19.
  • 2石玉华,曲中玉,陈子江.多囊卵巢综合征患者的远期健康风险[J].中华妇产科杂志,2008,43(7):548-549. 被引量:10
  • 3Knochenhauer ES,Key TJ,Kahsar-Miller M.Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States:A prospective study(J).J Clin Endocrinol Metab,1998,83:3078.
  • 4Michelmore KF,Balen AH,Dunger DB et al.Polycystic ova-ries and associated clinical and biochemical features in young women(J).Clin Endocrinol,1999,51:779.
  • 5陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 6Carmina E.Diagnosis of polycystic ovary syndrome:from NIH criteria to ESHRE-ASRM guidelines(J).Minerva Ginecol,2004,56:1.
  • 7Ricardo Azziz.Controversy in clinical endocrinology diagnosis of polycystic ovarian syndrome the Rotterdam criteria are pre-mature(J).J Clin Endocrinol Metab,2006,91(3):781.
  • 8Gambineri A,Pelusi C,Manicardi E et al.Glucose intoler-ance in a large cohort of Mediterranean women with polycystic ovary syndrome.Phenotype and associated factors(J).Diabe-tes,2004,53:2353.
  • 9Kumarapeli V,Seneviratne RA,Wijeyaratne CN et al.A simple screening approach for assessing community preva-lence and phenotype of polycystic ovary syndrome in a semi urban population in SriLanka(J).Am J Epidemiol,2008,168(3):321.
  • 10唐蓉辉,汤惠茹,王丽平,陈小琳,王玉洁,吴瑞芳.深圳市汉族育龄妇女多囊卵巢综合症患病率及临床特征分析[J].罕少疾病杂志,2010,17(1):1-5. 被引量:32

二级参考文献42

  • 1姚树新.多囊卵巢综合征的彩色多普勒超声诊断[J].罕少疾病杂志,2004,11(4):58-59. 被引量:1
  • 2陈子江,李媛,周灿权,黄荷凤,刘嘉茵,乔杰,黄国宁,梁晓燕,郁琦.多囊卵巢综合征与辅助生殖的热点问题讨论[J].现代妇产科进展,2004,13(4):241-250. 被引量:58
  • 3陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 4赵君利,陈子江,赵跃然,王来城,赵力新,唐蓉,马增香,石玉华.PAI-1基因4G/5G多态性与PCOS糖代谢、肥胖的相关性研究[J].实用妇产科杂志,2006,22(7):406-409. 被引量:4
  • 5Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol,2007, 50:168-177.
  • 6Shi Y, Guo M, Yan J, et al. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett ,2007,28 : 807-810.
  • 7Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol,1978,51:97-100.
  • 8Kurabayashi T, Kase H, Suzuki M,et al. Endometrial abnormalities in infertile women. J Reprod Med ,2003 ,48 :455-459.
  • 9Wijeyaratne CN, Balen AH, Barth JH, et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? Clin Endocrinol,2002 ,57 :343-350.
  • 10Kelestimur F, Unluhizarci K, Baybuga H, et al. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Fertil Steril, 2006,86 : 405 -410.

共引文献81

同被引文献38

  • 1谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2003:361.
  • 2Wang Y, Bian CA.Clomiphene is superior to metformin in achieving fertility in infertile women with the polycystic ovary syndrome[J].National Med J China, 2011,87 ( 21 ): 1477.
  • 3Amooee S, Parsanezhad ME, Ravanbod Shirazi M, et al. Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial[J].Iran J Reprod Med, 2013,11 (8): 611-618.
  • 4Lautatzis ME, Goulis DG, Vrontakis M.Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review[J].Metabolism,2013,62 ( 11 ) :1522-1534.
  • 5Ravn P, Haugen AG, Glintborg D.Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss[J].Minerva Endocrinol, 2013,38 ( 1 ) : 59-76.
  • 6Grigoryan O, Absatarova J, Andreeva E, et al.Effect of mefformin on the level of anti-Mullerian hormone in therapy of polycystie ovary syndrome in obese women[J]. Minerva Ginecol,2014,66 (1): 85-89.
  • 7Kruszyfiska A, S:owi fi ska-Srzednieka J, Jeske W, et al. Proinsulin, adiponectin and hsCRP in reproductive age women with polycystie ovary syndrome ( PCOS )-the effect of mefformin treatment[J].Endokrynol Pol, 2014,65 ( 1 ): 2-10.
  • 8彭璇,熊小娟,骆霞,雷美云,梅圆圆.达英-35治疗多囊卵巢综合征并不孕的临床观察[J].中国妇幼保健,2007,22(8):1077-1078. 被引量:15
  • 9李红真,乔杰,甄秀梅.重新评价克罗米芬在促排卵治疗中的作用[J].生殖医学杂志,2008,17(6):428-430. 被引量:34
  • 10徐成康.达英-35治疗后PCOS患者卵泡液中睾酮及白血病抑制因子水平的变化[J].中国妇幼保健,2010,25(2):230-232. 被引量:1

引证文献4

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部